<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33167518</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>11</Issue><PubDate><Year>2020</Year><Month>Nov</Month><Day>05</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Use of Animal Models in Studying Roles of Antibodies and Their Secretion Cells in Dengue Vaccine Development.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1261</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v12111261</ELocationID><Abstract><AbstractText>The cardinal feature of adaptive immunity is its ability to form memory responses that can be rapidly recalled to contain pathogens upon reencountering. Conferring a robust memory immune response to an infection is a key feature for a successful vaccination program. The plasmablasts are cells that not only can secret non-neutralizing antibodies but also can secrete the specific antibodies essential to neutralize and inactivate the invading pathogens. Dengue has been recognized as one of the most important vector-borne human viral diseases globally. Currently, supportive care with vigilant monitoring is the standard practice since there is as yet no approved therapeutic modality to treat dengue. Even though the approved vaccine has become available, its low efficacy with the potential to cause harm is the major hurdle to promote the widespread usage of the vaccine. Despite the decades of research on dengue, the major challenge in dengue vaccine development is the absence of suitable experimental animal models that reflect the pathological features and clinical symptoms, as seen in humans. Dengue is transmitted by the bite of mosquitoes carrying infectious dengue virus (DENV), which has four distinct serotypes. Recently, cases resulting from unconventional transmission routes, such as blood transfusion, organs as well as stem cells and bone marrow transplantations, and mother-to-infant vertical transmission, have been reported, suggesting an alternate route of DENV transmission exists in nature. This review discusses issues and challenges needing to be resolved to develop an effective dengue vaccine. Development of a robust and reliable dengue animal model that can reflect not only dynamic human clinical symptoms but also can answer around why preexisting neutralizing antibodies do not confer protection upon re-infection and immune protection marker for dengue vaccine efficacy evaluation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chokephaibulkit</LastName><ForeName>Kulkanya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Siriraj Institute of Clinical Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chien</LastName><ForeName>Yu-Wen</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Public Health, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Occupational and Environmental Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AbuBakar</LastName><ForeName>Sazaly</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Tropical Infectious Diseases Research and Education Centre (TIDREC), University of Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur 50603, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pattanapanyasat</LastName><ForeName>Kovit</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-1037-6610</Identifier><AffiliationInfo><Affiliation>Center of Research Excellence for Microparticle and Exosome in Diseases, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perng</LastName><ForeName>Guey Chuen</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701401, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053059">Dengue Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D056704" MajorTopicYN="N">Adaptive Immunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053059" MajorTopicYN="N">Dengue Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072138" MajorTopicYN="N">Mosquito Vectors</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010950" MajorTopicYN="N">Plasma Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">B cells</Keyword><Keyword MajorTopicYN="N">DHF/DSS</Keyword><Keyword MajorTopicYN="N">antibody secretion cells</Keyword><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">global health</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>10</Day><Hour>1</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33167518</ArticleId><ArticleId IdType="pmc">PMC7694450</ArticleId><ArticleId IdType="doi">10.3390/v12111261</ArticleId><ArticleId IdType="pii">v12111261</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nobuchi H. The symptoms of a dengue-loke illness recorded in a Chinese medical encyclopedia. Kanp Rinsho. 1979;26:422&#x2013;425. (In Japanese)</Citation></Reference><Reference><Citation>Simmons J.S. Dengue fever. Am. J. Trop. Med. 1931;11:77&#x2013;102. doi: 10.4269/ajtmh.1931.s1-11.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1931.s1-11.77</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Dengue Vaccine Development: The Role of the Who South-East Asia Regional Office. World Health Organization; Geneva, Switzerland: 2010.</Citation></Reference><Reference><Citation>WHO . Dengue and Dengue Hemorrhagic Fever. Vol. 117 World Health Organization; Geneva, Switzerland: 2009.</Citation></Reference><Reference><Citation>Burke D.S., Nisalak A., Johnson D.E., Scott R.M. A prospective study of dengue infections in Bangkok. Am. J. Trop. Med. Hyg. 1988;38:172&#x2013;180. doi: 10.4269/ajtmh.1988.38.172.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1988.38.172</ArticleId><ArticleId IdType="pubmed">3341519</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A., Standish K., Mercado J.C., Matute J.C., Tellez Y., Sabor&#xed;o S., Hammond S.N., Nu&#xf1;ez A., Avil&#xe9;s W., Henn M.R., et al. Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J. Infect. Dis. 2010;201:5&#x2013;14. doi: 10.1086/648592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/648592</ArticleId><ArticleId IdType="pmc">PMC3724236</ArticleId><ArticleId IdType="pubmed">19929380</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter K.R., Parwati I., Beckett C.G., Widjaja S., Sudjana P., Kosasih H., Wuryadi S., McArdle J.L., Alisjahbana B., Rudiman P.I.F., et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am. J. Trop. Med. Hyg. 2005;72:60&#x2013;66. doi: 10.4269/ajtmh.2005.72.60.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2005.72.60</ArticleId><ArticleId IdType="pubmed">15728868</ArticleId></ArticleIdList></Reference><Reference><Citation>Mammen M.P., Pimgate C., Koenraadt C.J.M., Rothman A.L., Aldstadt J., Nisalak A., Jarman R.G., Jones J.W., Srikiatkhachorn A., Ypil-Butac C.A., et al. Spatial and temporal clustering of dengue virus transmission in Thai villages. PLoS Med. 2008;5:e205. doi: 10.1371/journal.pmed.0050205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050205</ArticleId><ArticleId IdType="pmc">PMC2577695</ArticleId><ArticleId IdType="pubmed">18986209</ArticleId></ArticleIdList></Reference><Reference><Citation>Endy T.P., Anderson K.B., Nisalak A., Yoon I.-K., Green S., Rothman A.L., Thomas S.J., Jarman R.G., Libraty D.H., Gibbons R.V. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl. Trop. Dis. 2011;5:e975. doi: 10.1371/journal.pntd.0000975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000975</ArticleId><ArticleId IdType="pmc">PMC3046956</ArticleId><ArticleId IdType="pubmed">21390158</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong V., Lambrechts L., Paul R.E., Ly S., Lay R.S., Long K.C., Huy R., Tarantola A., Scott T.W., Sakuntabhai A., et al. Asymptomatic humans transmit dengue virus to mosquitoes. Proc. Nat. Acad. Sci. USA. 2015;112:14688&#x2013;14693. doi: 10.1073/pnas.1508114112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508114112</ArticleId><ArticleId IdType="pmc">PMC4664300</ArticleId><ArticleId IdType="pubmed">26553981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chastel C. Eventual role of asymptomatic cases of dengue for the introduction and spread of dengue viruses in non-endemic regions. Front. Physiol. 2012;3:70. doi: 10.3389/fphys.2012.00070.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2012.00070</ArticleId><ArticleId IdType="pmc">PMC3315825</ArticleId><ArticleId IdType="pubmed">22479252</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd ed. World Health Organization; Geneva, Switzerland: 1997. p. 84.</Citation></Reference><Reference><Citation>WHO . Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever, Revised and Expanded Edition. Vol. 60 World Health Organization; Geneva, Switzerland: 2011.</Citation></Reference><Reference><Citation>WHO . Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization; Geneva, Switzerland: 2009.</Citation></Reference><Reference><Citation>Siler J.F., Hall M.W., Hitchins A.P. Dengue: Its history, epidemiology, mechanism of transmission, etiology, clinical manifestations, immunity and prevention. Philipp. J. Sci. 1926;29:1&#x2013;340.</Citation></Reference><Reference><Citation>Simmons J.S., St. John J.H., Reynolds F.H.K. Experimental studies of dengue. Philipp. J. Sci. 1931;44:1&#x2013;251.</Citation></Reference><Reference><Citation>Sabin A.B. Research on dengue during world war ii. Am. J. Trop. Med. Hyg. 1952;1:30&#x2013;50. doi: 10.4269/ajtmh.1952.1.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1952.1.30</ArticleId><ArticleId IdType="pubmed">14903434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammon W.M., Rudnick A., Sather G.E. Viruses associated with epidemic hemorrhagic fevers of the Philippines and Thailand. Science. 1960;131:1102&#x2013;1103. doi: 10.1126/science.131.3407.1102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.131.3407.1102</ArticleId><ArticleId IdType="pubmed">14399343</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Observations related to pathogensis of dengue hemorrhagic fever. Vi. Hypotheses and discussion. Yale J. Biol. Med. 1970;42:350&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2591710</ArticleId><ArticleId IdType="pubmed">5419208</ArticleId></ArticleIdList></Reference><Reference><Citation>Waggoner J.J., Balmaseda A., Gresh L., Sahoo M.K., Montoya M., Wang C., Abeynayake J., Kuan G., Pinsky B.A., Harris E. Homotypic dengue virus reinfections in nicaraguan children. J. Infect. Dis. 2016;214:986&#x2013;993. doi: 10.1093/infdis/jiw099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw099</ArticleId><ArticleId IdType="pmc">PMC5021223</ArticleId><ArticleId IdType="pubmed">26984144</ArticleId></ArticleIdList></Reference><Reference><Citation>Forshey B.M., Reiner R.C., Olkowski S., Morrison A.C., Espinoza A., Long K.C., Vilcarromero S., Casanova W., Wearing H.J., Halsey E.S., et al. Incomplete protection against dengue virus type 2 re-infection in Peru. PLoS Negl. Trop. Dis. 2016;10:e0004398. doi: 10.1371/journal.pntd.0004398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004398</ArticleId><ArticleId IdType="pmc">PMC4746126</ArticleId><ArticleId IdType="pubmed">26848841</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp T.M., Hunsperger E., Munoz-Jordan J.L., Margolis H.S., Tomashek K.M. Sequential episodes of dengue&#x2014;Puerto Rico, 2005&#x2013;2010. Am. J. Trop. Med. Hyg. 2014;91:235&#x2013;239. doi: 10.4269/ajtmh.13-0742.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.13-0742</ArticleId><ArticleId IdType="pmc">PMC4125242</ArticleId><ArticleId IdType="pubmed">24891464</ArticleId></ArticleIdList></Reference><Reference><Citation>Endy T.P., Nisalak A., Chunsuttitwat S., Vaughn D.W., Green S., Ennis F.A., Rothman A.L., Libraty D.H. Relationship of preexisting dengue virus (dv) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of dv infection in Thailand. J. Infect. Dis. 2004;189:990&#x2013;1000. doi: 10.1086/382280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/382280</ArticleId><ArticleId IdType="pubmed">14999601</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Alvarez M., Halstead S.B. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: An historical perspective and role of antibody-dependent enhancement of infection. Arch. Virol. 2013;158:1445&#x2013;1459. doi: 10.1007/s00705-013-1645-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1645-3</ArticleId><ArticleId IdType="pubmed">23471635</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A.L. Immunity to dengue virus: A tale of original antigenic sin and tropical cytokine storms. Nat. Rev. Immunol. 2011;11:532&#x2013;543. doi: 10.1038/nri3014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3014</ArticleId><ArticleId IdType="pubmed">21760609</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A.L. Dengue: Defining protective versus pathologic immunity. J. Clin. Investig. 2004;113:946&#x2013;951. doi: 10.1172/JCI21512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI21512</ArticleId><ArticleId IdType="pmc">PMC379334</ArticleId><ArticleId IdType="pubmed">15057297</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar N.A., Allende I., Balmaseda A., Coelho I.C., da Cunha R.V., Datta B., Devi S.S., Farrar J., Gaczkowski R., Guzman M.G., et al. Regarding &#x201c;Dengue&#x2014;How best to classify it". Clin. Infect. Dis. 2012;54:1820&#x2013;1822. doi: 10.1093/cid/cis328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis328</ArticleId><ArticleId IdType="pubmed">22474173</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilder-Smith A., Schwartz E. Dengue in travelers. N. Engl. J. Med. 2005;353:924&#x2013;932. doi: 10.1056/NEJMra041927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra041927</ArticleId><ArticleId IdType="pubmed">16135837</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond S.N., Balmaseda A., Perez L., Tellez Y., Saborio S.I., Mercado J.C., Videa E., Rodriguez Y., Perez M.A., Cuadra R., et al. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. Am. J. Trop. Med. Hyg. 2005;73:1063&#x2013;1070. doi: 10.4269/ajtmh.2005.73.1063.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2005.73.1063</ArticleId><ArticleId IdType="pubmed">16354813</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp T.W., Wallace M.R., Hayes C.G., Sanchez J.L., DeFraites R.F., Arthur R.R., Thornton S.A., Batchelor R.A., Rozmajzl P.J., Hanson R.K., et al. Dengue fever in U.S. Troops during operation restore hope, Somalia, 1992&#x2013;1993. Am. J. Trop. Med. Hyg. 1995;53:89&#x2013;94. doi: 10.4269/ajtmh.1995.53.89.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1995.53.89</ArticleId><ArticleId IdType="pubmed">7625541</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Kouri G. Dengue and dengue hemorrhagic fever in the Americas: Lessons and challenges. J. Clin. Virol. 2003;27:1&#x2013;13. doi: 10.1016/S1386-6532(03)00010-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(03)00010-6</ArticleId><ArticleId IdType="pubmed">12727523</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilarde A.O., Turchi M.D., Siqueira J.B., Jr., Feres V.C., Rocha B., Levi J.E., Souza V.A., Boas L.S., Pannuti C.S., Martelli C.M. Dengue and dengue hemorrhagic fever among adults: Clinical outcomes related to viremia, serotypes, and antibody response. J. Infect. Dis. 2008;197:817&#x2013;824. doi: 10.1086/528805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/528805</ArticleId><ArticleId IdType="pubmed">18269315</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.C., Huang Y.H., Shu P.Y., Wu H.S., Lin Y.S., Yeh T.M., Liu H.S., Liu C.C., Lei H.Y. Characteristic of dengue disease in Taiwan: 2002&#x2013;2007. Am. J. Trop. Med. Hyg. 2010;82:731&#x2013;739. doi: 10.4269/ajtmh.2010.09-0549.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2010.09-0549</ArticleId><ArticleId IdType="pmc">PMC2844571</ArticleId><ArticleId IdType="pubmed">20348527</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi E.E., Goh K.T., Gubler D.J. Dengue prevention and 35 years of vector control in Singapore. Emerg. Infect. Dis. 2006;12:887&#x2013;893. doi: 10.3201/eid1206.051210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1206.051210</ArticleId><ArticleId IdType="pmc">PMC3373041</ArticleId><ArticleId IdType="pubmed">16707042</ArticleId></ArticleIdList></Reference><Reference><Citation>Messer W.B., Gubler D.J., Harris E., Sivananthan K., de Silva A.M. Emergence and global spread of a dengue serotype 3, subtype iii virus. Emerg. Infect. Dis. 2003;9:800&#x2013;809. doi: 10.3201/eid0907.030038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0907.030038</ArticleId><ArticleId IdType="pmc">PMC3023445</ArticleId><ArticleId IdType="pubmed">12899133</ArticleId></ArticleIdList></Reference><Reference><Citation>Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv. Virus Res. 2003;59:315&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3045824</ArticleId><ArticleId IdType="pubmed">14696333</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., Hunsperger E., Kroeger A., Margolis H.S., Martinez E., et al. Dengue: A continuing global threat. Nat. Rev. Microbiol. 2010;8:S7&#x2013;S16. doi: 10.1038/nrmicro2460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2460</ArticleId><ArticleId IdType="pmc">PMC4333201</ArticleId><ArticleId IdType="pubmed">21079655</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephens H.A., Klaythong R., Sirikong M., Vaughn D.W., Green S., Kalayanarooj S., Endy T.P., Libraty D.H., Nisalak A., Innis B.L., et al. Hla-a and -b allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens. 2002;60:309&#x2013;318. doi: 10.1034/j.1399-0039.2002.600405.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-0039.2002.600405.x</ArticleId><ArticleId IdType="pubmed">12472660</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J.-J., Liu L.-T., Chang K., Wang S.-H., Hsiao H.-M., Clark K.B., Perng G.C. The importance of hematopoietic progenitor cells in dengue. Ther. Adv. Hematol. 2012;3:59&#x2013;71. doi: 10.1177/2040620711417660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2040620711417660</ArticleId><ArticleId IdType="pmc">PMC3573426</ArticleId><ArticleId IdType="pubmed">23556112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bierman H.R., Nelson E.R. Hematodepressive virus diseases of Thailand. Ann. Intern. Med. 1965;62:867&#x2013;884. doi: 10.7326/0003-4819-62-5-867.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-62-5-867</ArticleId><ArticleId IdType="pubmed">14283387</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Summaries of papers presented at the who inter-regional seminar on mosquito-borne haemorrhagic fevers in the south-east Asia and western pacific regions. Bulletin. 1966;35:61&#x2013;62.</Citation></Reference><Reference><Citation>Sabin A.B. Electron microscope studies on human dengue serum. Am. J. Public Health. 1951;41:1215. doi: 10.2105/AJPH.41.10.1215.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.41.10.1215</ArticleId><ArticleId IdType="pmc">PMC1525657</ArticleId><ArticleId IdType="pubmed">14885514</ArticleId></ArticleIdList></Reference><Reference><Citation>Hase T., Summers P.L., Eckels K.H., Baze W.B. An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: Maturation events. Arch. Virol. 1987;92:273&#x2013;291. doi: 10.1007/BF01317484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317484</ArticleId><ArticleId IdType="pubmed">3813888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A.Y., Wu S.R., Tsai J.J., Chen P.L., Chen Y.P., Chen T.Y., Lo Y.C., Ho T.C., Lee M., Chen M.T., et al. Infectious dengue vesicles derived from cd61+ cells in acute patient plasma exhibited a diaphanous appearance. Sci. Rep. 2015;5:17990. doi: 10.1038/srep17990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17990</ArticleId><ArticleId IdType="pmc">PMC4675971</ArticleId><ArticleId IdType="pubmed">26657027</ArticleId></ArticleIdList></Reference><Reference><Citation>Raut R., Corbett K.S., Tennekoon R.N., Premawansa S., Wijewickrama A., Premawansa G., Mieczkowski P., Ruckert C., Ebel G.D., De Silva A.D., et al. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies. Proc. Nat. Acad. Sci. USA. 2019;116:227&#x2013;232. doi: 10.1073/pnas.1812055115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1812055115</ArticleId><ArticleId IdType="pmc">PMC6320508</ArticleId><ArticleId IdType="pubmed">30518559</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson E.R., Tuchinda S., Howard R., Chulajata R. Haematology of Thai haemorrhagic fever (dengue) Bull. World Health Organ. 1966;35:43&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2476140</ArticleId><ArticleId IdType="pubmed">20604238</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson E.R., Bierman H.R., Chulajata R. Hematologic phagocytosis in postmortem bone marrows of dengue hemorrhagic fever. (Hematologic phagocytosis in Thai hemorrhagic fever) Am. J. Med. Sci. 1966;252:68&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">4287434</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen L., Khin M.M., Tin U. Recovery of virus from the liver of children with fatal dengue: Reflections on the pathogenesis of the disease and its possible analogy with that of yellow fever. Res. Virol. 1989;140:351&#x2013;360. doi: 10.1016/S0923-2516(89)80115-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0923-2516(89)80115-3</ArticleId><ArticleId IdType="pubmed">2772416</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen L., Drouet M.T., Deubel V. Detection of dengue virus rna by reverse transcription-polymerase chain reaction in the liver and lymphoid organs but not in the brain in fatal human infection. Am. J. Trop. Med. Hyg. 1999;61:720&#x2013;724. doi: 10.4269/ajtmh.1999.61.720.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1999.61.720</ArticleId><ArticleId IdType="pubmed">10586901</ArticleId></ArticleIdList></Reference><Reference><Citation>Aye K.S., Charngkaew K., Win N., Wai K.Z., Moe K., Punyadee N., Thiemmeca S., Suttitheptumrong A., Sukpanichnant S., Prida M., et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy cases from myanmar. Hum. Pathol. 2014;45:1221&#x2013;1233. doi: 10.1016/j.humpath.2014.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humpath.2014.01.022</ArticleId><ArticleId IdType="pubmed">24767772</ArticleId></ArticleIdList></Reference><Reference><Citation>Ab-Rahman H.A., Wong P.F., Rahim H., Abd-Jamil J., Tan K.K., Sulaiman S., Lum C.S., Syed-Omar S.F., AbuBakar S. Dengue death with evidence of hemophagocytic syndrome and dengue virus infection in the bone marrow. SpringerPlus. 2015;4:665. doi: 10.1186/s40064-015-1463-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40064-015-1463-z</ArticleId><ArticleId IdType="pmc">PMC4630261</ArticleId><ArticleId IdType="pubmed">26558168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook G.C. Liver involvement in systemic infection. Eur. J. Gastroenterol. Hepatol. 1997;9:1239&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">9471032</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T.L., Nguyen T.H., Tieu N.T. The impact of dengue haemorrhagic fever on liver function. Res. Virol. 1997;148:273&#x2013;277. doi: 10.1016/S0923-2516(97)88364-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0923-2516(97)88364-1</ArticleId><ArticleId IdType="pubmed">9272578</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnamurti C., Kalayanarooj S., Cutting M.A., Peat R.A., Rothwell S.W., Reid T.J., Green S., Nisalak A., Endy T.P., Vaughn D.W., et al. Mechanisms of hemorrhage in dengue without circulatory collapse. Am. J. Trop. Med. Hyg. 2001;65:840&#x2013;847. doi: 10.4269/ajtmh.2001.65.840.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2001.65.840</ArticleId><ArticleId IdType="pubmed">11791984</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonpucknavig S., Vuttiviroj O., Bunnag C., Bhamarapravati N., Nimmanitya S. Demonstration of dengue antibody complexes on the surface of platelets from patients with dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 1979;28:881&#x2013;884. doi: 10.4269/ajtmh.1979.28.881.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1979.28.881</ArticleId><ArticleId IdType="pubmed">384817</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J.J., Chokephaibulkit K., Chen P.C., Liu L.T., Hsiao H.M., Lo Y.C., Perng G.C. Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome. J. Biomed. Sci. 2013;20:88. doi: 10.1186/1423-0127-20-88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-88</ArticleId><ArticleId IdType="pmc">PMC4174897</ArticleId><ArticleId IdType="pubmed">24305068</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A., Hammond S.N., Perez L., Tellez Y., Saborio S.I., Mercado J.C., Cuadra R., Rocha J., Perez M.A., Silva S., et al. Serotype-specific differences in clinical manifestations of dengue. Am. J. Trop. Med. Hyg. 2006;74:449&#x2013;456. doi: 10.4269/ajtmh.2006.74.449.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2006.74.449</ArticleId><ArticleId IdType="pubmed">16525106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I., Rothman A.L., Livingston P.G., Green S., Gagnon S.J., Janus J., Innis B.L., Nimmannitya S., Nisalak A., Ennis F.A. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch. Virol. Suppl. 1994;9:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">8032282</ArticleId></ArticleIdList></Reference><Reference><Citation>I.M.R. Dengue Fever Studies in Malaysia. Vol. 23 The Institute for Medical Research; Kuala Lumpur, Malaysia: 1986.</Citation></Reference><Reference><Citation>Blanc G., Caminopetros J. Contributions to the study of vaccination against dengue. Bull. Acad. Med. 1929;102:40&#x2013;47.</Citation></Reference><Reference><Citation>Cleland J.B., Bradley B., Macdonald W. Further experiments in the etiology of dengue fever. J. Hyg. 1919;18:217&#x2013;254. doi: 10.1017/S0022172400007476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0022172400007476</ArticleId><ArticleId IdType="pmc">PMC2206837</ArticleId><ArticleId IdType="pubmed">20474685</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura R., Hotta S. Studies on dengue fever (vi). On the inoculation of dengue virus into mice. Nippom Igaku. 1944;3379:629&#x2013;633. (In Japanese)</Citation></Reference><Reference><Citation>Hotta S. Experimental studies on dengue i isolation, identification and modification of the virus. J. Infect. Dis. 1952;90:1&#x2013;9. doi: 10.1093/infdis/90.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/90.1.1</ArticleId><ArticleId IdType="pubmed">14888958</ArticleId></ArticleIdList></Reference><Reference><Citation>Azami N.A.M., Takasaki T., Kurane I., Moi M.L. Non-human primate models of dengue virus infection: A comparison of viremia levels and antibody responses during primary and secondary infection among old world and new world monkeys. Pathogens. 2020;9:247. doi: 10.3390/pathogens9040247.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9040247</ArticleId><ArticleId IdType="pmc">PMC7238212</ArticleId><ArticleId IdType="pubmed">32230836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarathy V.V., White M., Li L., Kaiser J.A., Campbell G.A., Milligan G.N., Bourne N., Barrett A.D.T. Characterization of a murine model of non-lethal, symptomatic dengue virus infection. Sci. Rep. 2018;8:4900. doi: 10.1038/s41598-018-22618-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-22618-w</ArticleId><ArticleId IdType="pmc">PMC5861036</ArticleId><ArticleId IdType="pubmed">29559699</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronel-Ruiz C., Gutierrez-Barbosa H., Medina-Moreno S., Velandia-Romero M.L., Chua J.V., Castellanos J.E., Zapata J.C. Humanized mice in dengue research: A comparison with other mouse models. Vaccines. 2020;8:39. doi: 10.3390/vaccines8010039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines8010039</ArticleId><ArticleId IdType="pmc">PMC7157640</ArticleId><ArticleId IdType="pubmed">31979145</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos E.A., Fink K. Animal models for dengue and zika vaccine development. Adv. Exp. Med. Biol. 2018;1062:215&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pubmed">29845536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bente D.A., Rico-Hesse R. Models of dengue virus infection. Drug Discov. Today Dis. Models. 2006;3:97&#x2013;103. doi: 10.1016/j.ddmod.2006.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ddmod.2006.03.014</ArticleId><ArticleId IdType="pmc">PMC1949394</ArticleId><ArticleId IdType="pubmed">18087566</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A. Humanized mouse models to study human cell-mediated and humoral responses to dengue virus. Curr. Opin. Virol. 2017;25:76&#x2013;80. doi: 10.1016/j.coviro.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5769147</ArticleId><ArticleId IdType="pubmed">28802204</ArticleId></ArticleIdList></Reference><Reference><Citation>St. John A.L., Rathore A.P., Raghavan B., Ng M.L., Abraham S.N. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. eLife. 2013;2:e00481. doi: 10.7554/eLife.00481.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.00481</ArticleId><ArticleId IdType="pmc">PMC3639510</ArticleId><ArticleId IdType="pubmed">23638300</ArticleId></ArticleIdList></Reference><Reference><Citation>Bente D.A., Melkus M.W., Garcia J.V., Rico-Hesse R. Dengue fever in humanized nod/scid mice. J. Virol. 2005;79:13797&#x2013;13799. doi: 10.1128/JVI.79.21.13797-13799.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.21.13797-13799.2005</ArticleId><ArticleId IdType="pmc">PMC1262615</ArticleId><ArticleId IdType="pubmed">16227299</ArticleId></ArticleIdList></Reference><Reference><Citation>Mota J., Rico-Hesse R. Humanized mice show clinical signs of dengue fever according to infecting virus genotype. J. Virol. 2009;83:8638&#x2013;8645. doi: 10.1128/JVI.00581-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00581-09</ArticleId><ArticleId IdType="pmc">PMC2738212</ArticleId><ArticleId IdType="pubmed">19535452</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan A., Chen Q., Tang K.F., Ooi E.E., Hibberd M.L., Chen J. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J. Virol. 2013;87:11648&#x2013;11658. doi: 10.1128/JVI.01156-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01156-13</ArticleId><ArticleId IdType="pmc">PMC3807371</ArticleId><ArticleId IdType="pubmed">23966397</ArticleId></ArticleIdList></Reference><Reference><Citation>Wege A.K., Melkus M.W., Denton P.W., Estes J.D., Garcia J.V. Functional and phenotypic characterization of the humanized blt mouse model. Curr. Top. Microbiol. Immunol. 2008;324:149&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">18481459</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal S., Smith K., Ramirez A., Woda M., Pazoles P., Shultz L.D., Greiner D.L., Brehm M.A., Mathew A. Dengue virus infection induces broadly cross-reactive human igm antibodies that recognize intact virions in humanized blt-nsg mice. Exp. Biol. Med. 2015;240:67&#x2013;78. doi: 10.1177/1535370214546273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370214546273</ArticleId><ArticleId IdType="pmc">PMC4446989</ArticleId><ArticleId IdType="pubmed">25125497</ArticleId></ArticleIdList></Reference><Reference><Citation>Shresta S., Sharar K.L., Prigozhin D.M., Snider H.M., Beatty P.R., Harris E. Critical roles for both stat1-dependent and stat1-independent pathways in the control of primary dengue virus infection in mice. J. Immunol. 2005;175:3946&#x2013;3954. doi: 10.4049/jimmunol.175.6.3946.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.6.3946</ArticleId><ArticleId IdType="pubmed">16148142</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Ng M.M., Chu J.J. Molecular profiling of t-helper immune genes during dengue virus infection. Virol. J. 2008;5:165. doi: 10.1186/1743-422X-5-165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-5-165</ArticleId><ArticleId IdType="pmc">PMC2628356</ArticleId><ArticleId IdType="pubmed">19117515</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry S.T., Buck M.D., Lada S.M., Schindler C., Shresta S. Stat2 mediates innate immunity to dengue virus in the absence of stat1 via the type i interferon receptor. PLoS Pathog. 2011;7:e1001297. doi: 10.1371/journal.ppat.1001297.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001297</ArticleId><ArticleId IdType="pmc">PMC3040673</ArticleId><ArticleId IdType="pubmed">21379341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zust R., Toh Y.X., Valdes I., Cerny D., Heinrich J., Hermida L., Marcos E., Guillen G., Kalinke U., Shi P.Y., et al. Type i interferon signals in macrophages and dendritic cells control dengue virus infection: Implications for a new mouse model to test dengue vaccines. J. Virol. 2014;88:7276&#x2013;7285. doi: 10.1128/JVI.03827-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03827-13</ArticleId><ArticleId IdType="pmc">PMC4054447</ArticleId><ArticleId IdType="pubmed">24741106</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassetti M.C., Durbin A., Harris E., Rico-Hesse R., Roehrig J., Rothman A., Whitehead S., Natarajan R., Laughlin C. Report of an niaid workshop on dengue animal models. Vaccine. 2010;28:4229&#x2013;4234. doi: 10.1016/j.vaccine.2010.04.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.04.045</ArticleId><ArticleId IdType="pmc">PMC2919823</ArticleId><ArticleId IdType="pubmed">20434551</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.J. Dengue human infection model: Re-establishing a tool for understanding dengue immunology and advancing vaccine development. Hum. Vaccines Immunother. 2013;9:1587&#x2013;1590. doi: 10.4161/hv.24188.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24188</ArticleId><ArticleId IdType="pubmed">23466948</ArticleId></ArticleIdList></Reference><Reference><Citation>Durbin A.P., Whitehead S.S. The dengue human challenge model: Has the time come to accept this challenge? J. Infect. Dis. 2013;207:697&#x2013;699. doi: 10.1093/infdis/jis749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis749</ArticleId><ArticleId IdType="pubmed">23225898</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y.W., Wang C.C., Wang Y.P., Lee C.Y., Perng G.C. Risk of leukemia after dengue virus infection: A population-based cohort study. Cancer Epidemiol. Biomark. Prev. 2020;29:558&#x2013;564. doi: 10.1158/1055-9965.EPI-19-1214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-19-1214</ArticleId><ArticleId IdType="pubmed">32051189</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott H. Dengue. II Edward Arnold &amp; Co.; London, UK: 1939.</Citation></Reference><Reference><Citation>Bosch Q.A.T., Clapham H.E., Lambrechts L., Duong V., Buchy P., Althouse B.M., Lloyd A.L., Waller L.A., Morrison A.C., Kitron U., et al. Contributions from the silent majority dominate dengue virus transmission. PLoS Pathog. 2018;14:e1006965.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5933708</ArticleId><ArticleId IdType="pubmed">29723307</ArticleId></ArticleIdList></Reference><Reference><Citation>Stramer S.L., Linnen J.M., Carrick J.M., Foster G.A., Krysztof D.E., Zou S., Dodd R.Y., Tirado-Marrero L.M., Hunsperger E., Santiago G.A., et al. Dengue viremia in blood donors identified by rna and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion. 2012;52:1657&#x2013;1666. doi: 10.1111/j.1537-2995.2012.03566.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2012.03566.x</ArticleId><ArticleId IdType="pubmed">22339201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y.W., Shu Y.C., Chuang K.T., Yeh C.Y., Ko W.C., Ko N.Y., Perng G.C. High estimated prevalence of asymptomatic dengue viremia in blood donors during a dengue epidemic in southern Taiwan, 2015. Transfusion. 2017;57:2649&#x2013;2656. doi: 10.1111/trf.14281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.14281</ArticleId><ArticleId IdType="pubmed">28840606</ArticleId></ArticleIdList></Reference><Reference><Citation>Chien Y.W., Huang H.M., Ho T.C., Tseng F.C., Ko N.Y., Ko W.C., Perng G.C. Seroepidemiology of dengue virus infection among adults during the ending phase of a severe dengue epidemic in southern taiwan, 2015. BMC Infect. Dis. 2019;19:338. doi: 10.1186/s12879-019-3946-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-3946-y</ArticleId><ArticleId IdType="pmc">PMC6480438</ArticleId><ArticleId IdType="pubmed">31014263</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Lew R., Innis B.L., Kurane I., Rothman A.L., et al. Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J. Infect. Dis. 1999;179:755&#x2013;762. doi: 10.1086/314680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314680</ArticleId><ArticleId IdType="pubmed">10068569</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Suntayakorn S., Nisalak A., Rothman A.L., Ennis F.A. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 1999;59:329&#x2013;334. doi: 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G</ArticleId><ArticleId IdType="pubmed">10502265</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Endy T.P., Raengsakulrach B., Rothman A.L., Ennis F.A., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J. Infect. Dis. 2000;181:2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Libraty D.H., Young P.R., Pickering D., Endy T.P., Kalayanarooj S., Green S., Vaughn D.W., Nisalak A., Ennis F.A., Rothman A.L. High circulating levels of the dengue virus nonstructural protein ns1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J. Infect. Dis. 2002;186:1165&#x2013;1168. doi: 10.1086/343813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/343813</ArticleId><ArticleId IdType="pubmed">12355369</ArticleId></ArticleIdList></Reference><Reference><Citation>Beltramello M., Williams K.L., Simmons C.P., Macagno A., Simonelli L., Quyen N.T., Sukupolvi-Petty S., Navarro-Sanchez E., Young P.R., de Silva A.M., et al. The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity. Cell Host Microbe. 2010;8:271&#x2013;283. doi: 10.1016/j.chom.2010.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC3884547</ArticleId><ArticleId IdType="pubmed">20833378</ArticleId></ArticleIdList></Reference><Reference><Citation>Srichaikul T., Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Best Pract. Res. Clin. Haematol. 2000;13:261&#x2013;276. doi: 10.1053/beha.2000.0073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/beha.2000.0073</ArticleId><ArticleId IdType="pubmed">10942625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalayanarooj S., Vaughn D.W., Nimmannitya S., Green S., Suntayakorn S., Kunentrasai N., Viramitrachai W., Ratanachu-eke S., Kiatpolpoj S., Innis B.L., et al. Early clinical and laboratory indicators of acute dengue illness. J. Infect. Dis. 1997;176:313&#x2013;321. doi: 10.1086/514047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/514047</ArticleId><ArticleId IdType="pubmed">9237695</ArticleId></ArticleIdList></Reference><Reference><Citation>Green S., Pichyangkul S., Vaughn D.W., Kalayanarooj S., Nimmannitya S., Nisalak A., Kurane I., Rothman A.L., Ennis F.A. Early cd69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever. J. Infect. Dis. 1999;180:1429&#x2013;1435. doi: 10.1086/315072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315072</ArticleId><ArticleId IdType="pubmed">10515800</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew A., Kurane I., Green S., Vaughn D.W., Kalayanarooj S., Suntayakorn S., Ennis F.A., Rothman A.L. Impaired t cell proliferation in acute dengue infection. J. Immunol. 1999;162:5609&#x2013;5615.</Citation><ArticleIdList><ArticleId IdType="pubmed">10228044</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon S.J., Ennis F.A., Rothman A.L. Bystander target cell lysis and cytokine production by dengue virus-specific human cd4(+) cytotoxic t-lymphocyte clones. J. Virol. 1999;73:3623&#x2013;3629. doi: 10.1128/JVI.73.5.3623-3629.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.5.3623-3629.1999</ArticleId><ArticleId IdType="pmc">PMC104137</ArticleId><ArticleId IdType="pubmed">10196254</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurane I., Ennis F.A. Immunopathogenesis of dengue virus infections. In: Gubler D.J., Kuno G., editors. Dengue and Dengue Hemorrhagic Fever. CAB International; Wallingford, UK: 1997. pp. 273&#x2013;290.</Citation></Reference><Reference><Citation>Vaughn D.W., Green S., Kalayanarooj S., Innis B.L., Nimmannitya S., Suntayakorn S., Rothman A.L., Ennis F.A., Nisalak A. Dengue in the early febrile phase: Viremia and antibody responses. J. Infect. Dis. 1997;176:322&#x2013;330. doi: 10.1086/514048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/514048</ArticleId><ArticleId IdType="pubmed">9237696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Vargas L.A., Kounlavouth S., Smith M.L., Anderson K.B., Srikiatkhachorn A., Ellison D.W., Currier J.R., Endy T.P., Mathew A., Rothman A.L. Longitudinal analysis of memory b and t cell responses to dengue virus in a 5-year prospective cohort study in thailand. Front. Immunol. 2019;10:1359. doi: 10.3389/fimmu.2019.01359.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01359</ArticleId><ArticleId IdType="pmc">PMC6585174</ArticleId><ArticleId IdType="pubmed">31263466</ArticleId></ArticleIdList></Reference><Reference><Citation>Friberg H., Bashyam H., Toyosaki-Maeda T., Potts J.A., Greenough T., Kalayanarooj S., Gibbons R.V., Nisalak A., Srikiatkhachorn A., Green S., et al. Cross-reactivity and expansion of dengue-specific t cells during acute primary and secondary infections in humans. Sci. Rep. 2011;1:51. doi: 10.1038/srep00051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00051</ArticleId><ArticleId IdType="pmc">PMC3216538</ArticleId><ArticleId IdType="pubmed">22355570</ArticleId></ArticleIdList></Reference><Reference><Citation>Thein T.L., Ng E.L., Yeang M.S., Leo Y.S., Lye D.C. Risk factors for concurrent bacteremia in adult patients with dengue. J. Microbiol. Immunol. Infect. 2017;50:314&#x2013;320. doi: 10.1016/j.jmii.2015.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2015.06.008</ArticleId><ArticleId IdType="pubmed">26338309</ArticleId></ArticleIdList></Reference><Reference><Citation>Syue L.S., Tang H.J., Hung Y.P., Chen P.L., Li C.W., Li M.C., Tsai P.F., Liu C.C., Lee N.Y., Ko W.C. Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy. J. Microbiol. Immunol. Infect. 2019;52:225&#x2013;232. doi: 10.1016/j.jmii.2018.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2018.11.003</ArticleId><ArticleId IdType="pubmed">30528336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranjit S., Kissoon N., Gandhi D., Dayal A., Rajeshwari N., Kamath S.R. Early differentiation between dengue and septic shock by comparison of admission hemodynamic, clinical, and laboratory variables: A pilot study. Pediatr. Emerg. Care. 2007;23:368&#x2013;375. doi: 10.1097/01.pec.0000278403.22450.a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.pec.0000278403.22450.a2</ArticleId><ArticleId IdType="pubmed">17572519</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng G.C., Chokephaibulkit K. Immunologic hypo- or non-responder in natural dengue virus infection. J. Biomed. Sci. 2013;20:34. doi: 10.1186/1423-0127-20-34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-34</ArticleId><ArticleId IdType="pmc">PMC3680176</ArticleId><ArticleId IdType="pubmed">23725050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.K., Chen H.L., Yang C.F., Hsieh S.C., Juan C.C., Chang S.M., Yu C.C., Lin L.H., Huang J.H., King C.C. Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin. Infect. Dis. 2006;43:1023&#x2013;1030. doi: 10.1086/507635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/507635</ArticleId><ArticleId IdType="pubmed">16983615</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy B.R., Whitehead S.S. Immune response to dengue virus and prospects for a vaccine. Annu. Rev. Immunol. 2011;29:587&#x2013;619. doi: 10.1146/annurev-immunol-031210-101315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-031210-101315</ArticleId><ArticleId IdType="pubmed">21219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas S.J., Endy T.P. Vaccines for the prevention of dengue: Development update. Hum. Vaccines. 2011;7:674&#x2013;684. doi: 10.4161/hv.7.6.14985.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.7.6.14985</ArticleId><ArticleId IdType="pubmed">21508679</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster D.P., Farrar J., Rowland-Jones S. Progress towards a dengue vaccine. Lancet Infect. Dis. 2009;9:678&#x2013;687. doi: 10.1016/S1473-3099(09)70254-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(09)70254-3</ArticleId><ArticleId IdType="pubmed">19850226</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitz J., Roehrig J., Barrett A., Hombach J. Next generation dengue vaccines: A review of candidates in preclinical development. Vaccine. 2011;29:7276&#x2013;7284. doi: 10.1016/j.vaccine.2011.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.07.017</ArticleId><ArticleId IdType="pubmed">21781998</ArticleId></ArticleIdList></Reference><Reference><Citation>Swaminathan S., Batra G., Khanna N. Dengue vaccines: State of the art. Expert Opin. Ther. Pat. 2010;20:819&#x2013;835. doi: 10.1517/13543771003767476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/13543771003767476</ArticleId><ArticleId IdType="pubmed">20384534</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusman M.G. Dengue vaccines: New developments. Drugs Future. 2011;36:45&#x2013;62. doi: 10.1358/dof.2011.036.01.1583182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1358/dof.2011.036.01.1583182</ArticleId></ArticleIdList></Reference><Reference><Citation>Perng G.C., Lei H.Y., Lin Y.S., Choekphaibulkit K. Dengue vaccines: Challenge and confrotation. World J. Vaccines. 2011;1:109&#x2013;130. doi: 10.4236/wjv.2011.14012.</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/wjv.2011.14012</ArticleId></ArticleIdList></Reference><Reference><Citation>Capeding M.R., Tran N.H., Hadinegoro S.R., Ismail H.I., Chotpitayasunondh T., Chua M.N., Luong C.Q., Rusmil K., Wirawan D.N., Nallusamy R., et al. Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: A phase 3, randomised, observer-masked, placebo-controlled trial. Lancet. 2014;384:1358&#x2013;1365. doi: 10.1016/S0140-6736(14)61060-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61060-6</ArticleId><ArticleId IdType="pubmed">25018116</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar L., Dayan G.H., Arredondo-Garcia J.L., Rivera D.M., Cunha R., Deseda C., Reynales H., Costa M.S., Morales-Ramirez J.O., Carrasquilla G., et al. Efficacy of a tetravalent dengue vaccine in children in latin America. N. Engl. J. Med. 2015;372:113&#x2013;123. doi: 10.1056/NEJMoa1411037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1411037</ArticleId><ArticleId IdType="pubmed">25365753</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng K.H., Zhang S.L., Tan H.C., Kwek S.S., Sessions O.M., Chan C.Y., Liu I.D., Lee C.K., Tambyah P.A., Ooi E.E., et al. Persistent dengue infection in an immunosuppressed patient reveals the roles of humoral and cellular immune responses in virus clearance. Cell Host Microbe. 2019;26:601&#x2013;605.e603. doi: 10.1016/j.chom.2019.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2019.10.005</ArticleId><ArticleId IdType="pubmed">31676304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotta S. Viral infection in indonesia&#x2014;Immuno-epidemiological studies. Kansenshogaku Zasshi. 1971;45:211&#x2013;217.</Citation><ArticleIdList><ArticleId IdType="pubmed">4327198</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnen J.M., Vinelli E., Sabino E.C., Tobler L.H., Hyland C., Lee T.H., Kolk D.P., Broulik A.S., Collins C.S., Lanciotti R.S., et al. Dengue viremia in blood donors from Honduras, Brazil, and Australia. Transfusion. 2008;48:1355&#x2013;1362. doi: 10.1111/j.1537-2995.2008.01772.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1537-2995.2008.01772.x</ArticleId><ArticleId IdType="pubmed">18503610</ArticleId></ArticleIdList></Reference><Reference><Citation>Punzel M., Korukluoglu G., Caglayik D.Y., Menemenlioglu D., Bozdag S.C., Tekgunduz E., Altuntas F., Campos Rde M., Burde B., Gunther S., et al. Dengue virus transmission by blood stem cell donor after travel to Sri Lanka; Germany, 2013. Emerg. Infect. Dis. 2014;20:1366&#x2013;1369. doi: 10.3201/eid2008.140508.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2008.140508</ArticleId><ArticleId IdType="pmc">PMC4111198</ArticleId><ArticleId IdType="pubmed">25062084</ArticleId></ArticleIdList></Reference><Reference><Citation>Visuthranukul J., Bunworasate U., Lawasut P., Suankratay C. Dengue hemorrhagic fever in a peripheral blood stem cell transplant recipient: The first case report. Infect. Dis. Rep. 2009;1:e3. doi: 10.4081/idr.2009.1338.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/idr.2009.1338</ArticleId><ArticleId IdType="pmc">PMC3892570</ArticleId><ArticleId IdType="pubmed">24470881</ArticleId></ArticleIdList></Reference><Reference><Citation>Chotigeat U., Kalayanarooj S., Nisalak A. Vertical transmission of dengue infection in Thai infants: Two case reports. J. Med. Assoc. Thai. 2003;86(Suppl. 3):S628&#x2013;S632.</Citation><ArticleIdList><ArticleId IdType="pubmed">14700159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro C.F., Lopes V.G., Brasil P., Coelho J., Muniz A.G., Nogueira R.M. Perinatal transmission of dengue: A report of 7 cases. J. Pediatr. 2013;163:1514&#x2013;1516. doi: 10.1016/j.jpeds.2013.06.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2013.06.040</ArticleId><ArticleId IdType="pubmed">23916226</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu A.Y., Ho T.C., Lai M.L., Tan S.S., Chen T.Y., Lee M., Chien Y.W., Chen Y.P., Perng G.C. Identification and characterization of permissive cells to dengue virus infection in human hematopoietic stem and progenitor cells. Transfusion. 2019;59:2938&#x2013;2951. doi: 10.1111/trf.15416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.15416</ArticleId><ArticleId IdType="pubmed">31251408</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman A.L. Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 2003;60:397&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">14689699</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Pathogenesis of dengue: Challenges to molecular biology. Science. 1988;239:476&#x2013;481. doi: 10.1126/science.239.4839.476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.239.4839.476</ArticleId><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagbami A., Halstead S.B., Marchette N., Larsen K. Heterologous flavivirus infection-enhancing antibodies in sera of nigerians. Am. J. Trop. Med. Hyg. 1988;38:205&#x2013;207. doi: 10.4269/ajtmh.1988.38.205.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.1988.38.205</ArticleId><ArticleId IdType="pubmed">2829637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruechusatsawat K., Morita K., Tanaka M., Vongcheree S., Rojanasuphot S., Warachit P., Kanai K., Thongtradol P., Nimnakorn P., Kanungkid S., et al. Daily observation of antibody levels among dengue patients detected by Enzyme-Linked Immunosorbent Assay (ELISA) Jpn. J. Trop. Med. Hyg. 1994;22:9&#x2013;12. doi: 10.2149/tmh1973.22.9.</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh1973.22.9</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>